Optomed Oyj (HEL:OPTOMED)
Finland · Delayed Price · Currency is EUR 1.580
+0.016 (1.02%)
May 8, 2026, 10:26 AM EET
Optomed Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 16.43 | 17.1 | 15.04 | 15.1 | 14.66 | 14.85 |
Other Revenue | 0 | - | - | - | - | - |
| 16.43 | 17.1 | 15.04 | 15.1 | 14.66 | 14.85 | |
Revenue Growth (YoY) | 4.41% | 13.67% | -0.40% | 3.00% | -1.28% | 12.77% |
Cost of Revenue | 5.94 | 6.22 | 5.37 | 4.86 | 5.45 | 5.1 |
Gross Profit | 10.48 | 10.87 | 9.67 | 10.24 | 9.21 | 9.75 |
Selling, General & Admin | 10.7 | 10.82 | 9.64 | 9.33 | 9.61 | 9.38 |
Other Operating Expenses | 3.28 | 3.58 | 3.49 | 2.69 | 2.39 | 2.91 |
Operating Expenses | 16.55 | 16.92 | 15.43 | 14.2 | 14.11 | 14.5 |
Operating Income | -6.07 | -6.04 | -5.77 | -3.95 | -4.9 | -4.75 |
Interest Expense | - | -0.11 | -0.16 | -0.2 | -0.12 | -0.1 |
Interest & Investment Income | 0.25 | 0.12 | 0.18 | 0.02 | 0 | 0.02 |
Currency Exchange Gain (Loss) | -0.34 | -0.34 | 0.5 | -0.31 | -0.2 | 0.47 |
Other Non Operating Income (Expenses) | -0.08 | -0.34 | -0.08 | -0.05 | -0.15 | 0.07 |
EBT Excluding Unusual Items | -6.24 | -6.72 | -5.33 | -4.5 | -5.35 | -4.29 |
Asset Writedown | - | - | -0.19 | -0.02 | -1.04 | -0.57 |
Other Unusual Items | - | - | - | - | 0.84 | 0.54 |
Pretax Income | -6.24 | -6.72 | -5.52 | -4.52 | -5.55 | -4.33 |
Income Tax Expense | -0.08 | -0.08 | -0.07 | -0.08 | -0.08 | -0.08 |
Earnings From Continuing Operations | - | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Net Income to Company | - | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Net Income | -6.16 | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Net Income to Common | -6.16 | -6.64 | -5.45 | -4.44 | -5.47 | -4.25 |
Shares Outstanding (Basic) | 20 | 20 | 19 | 17 | 15 | 13 |
Shares Outstanding (Diluted) | 20 | 20 | 19 | 17 | 15 | 13 |
Shares Change (YoY) | 4.71% | 6.08% | 11.78% | 14.11% | 8.92% | 1.35% |
EPS (Basic) | -0.31 | -0.34 | -0.29 | -0.27 | -0.37 | -0.32 |
EPS (Diluted) | -0.31 | -0.34 | -0.29 | -0.27 | -0.37 | -0.32 |
Free Cash Flow | -4.76 | -3.04 | -1.87 | -0.83 | -3.15 | -3.4 |
Free Cash Flow Per Share | -0.24 | -0.15 | -0.10 | -0.05 | -0.21 | -0.25 |
Gross Margin | 63.82% | 63.61% | 64.27% | 67.83% | 62.83% | 65.64% |
Operating Margin | -36.94% | -35.34% | -38.34% | -26.18% | -33.41% | -31.97% |
Profit Margin | -37.50% | -38.84% | -36.24% | -29.41% | -37.33% | -28.61% |
Free Cash Flow Margin | -28.96% | -17.80% | -12.44% | -5.48% | -21.49% | -22.91% |
EBITDA | -5.31 | -5.34 | -5.1 | -3.28 | -4.12 | -3.99 |
EBITDA Margin | -32.30% | -31.25% | -33.88% | -21.69% | -28.10% | -26.87% |
D&A For EBITDA | 0.76 | 0.7 | 0.67 | 0.68 | 0.78 | 0.76 |
EBIT | -6.07 | -6.04 | -5.77 | -3.95 | -4.9 | -4.75 |
EBIT Margin | -36.94% | -35.34% | -38.34% | -26.18% | -33.41% | -31.97% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.